To explore whether the upregulation of FBXO9 expression is a key part of the cancer-promoting effect of ZNF143 in HCC, plasmids with shFBXO9 were transfected into ZNF143-overexpressing cells to silence FBXO9 expression. The gene discussed is FBXO9; the disease is hepatocellular carcinoma.